Source: Pharmaceutical Processing

Precision BioLogic: Precision BioLogic Acquires Affinity Biologicals

NewsPrecision BioLogic Inc. has completed the acquisition of Affinity Biologicals Inc., a manufacturer of reagents and kits used in hemostasis and thrombosis research and diagnostics.Contributed Author: Precision BioLogic Topics: Pharmaceutical Processing

Read full article »
Precision BioLogic's Competitors | Precision BioLogic's News | Precision BioLogic's Financials
Stay up-to-date with the latest news on Precision BioLogic
Est. Annual Revenue
$5.0-25M
Est. Employees
100-250
Paul Empey's photo - President & CEO of Precision BioLogic

President & CEO

Paul Empey

CEO Approval Rating

70/100

Read more
Stay up-to-date with the latest news on Precision BioLogic